Codexis (CDXS) Tops Q4 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Codexis (CDXS) Tops Q4 EPS by 6c

Codexis Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 24, 2022 4:05 PM EST

Record Annual Total Revenue of $104.8M, Representing Eighth Consecutive Year of Revenue Growth

Company Guides to 2022 Total Revenues of $152-$158M; Product Revenues of $112-$118M

REDWOOD CITY, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021 and provided a business update.

2021 was an exceptional year for Codexis, as we more than... More